Aytu Biopharma Inc expected to post a loss of 64 cents a share - Earnings Preview

Aytu Biopharma

13/05/2024 22:30

* Aytu Biopharma Inc  AYTU.OQ   AYTU.O  is expected to show
a fall
in quarterly revenue when it reports  results on May 15 for the
period ending March 31 2024
    * The Denver Colorado-based  company is expected to report a
23.7% decrease in revenue to $17.346 million from $22.73 million
a year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Aytu Biopharma Inc is
for a
loss of 64 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aytu
Biopharma
Inc is $8.00​, above​ its last closing price of $3.27. ​​​

This summary was machine generated May 13 at 21:29 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)